What people should know about endometrial cancer screening

Dr. Matt Boente MD has been an integral part of the National Comprehensive Cancer Network (NCCN) cervix and endometrial cancer screening task force, a committee that defined the standards of care for screening for the two diseases. Over the years, he has used his expertise and knowledge in the battle against cancer, sharing valuable information on his new series of blogs.

Image source: cancer.gov

Image source: cancer.gov
On that note, Dr. Matt Boente MD shares in this blog post a few important facts on endometrial cancer screening that everyone should know.

Screenings and tests are performed to look for different types of cancer that a woman may have even if she does not have the symptoms. Screening trials are also conducted to see if there is a significant correlation between early detection, meaning finding cancer before symptoms appear, and prolonging a patient’s life.

Typically, there is a high chance of recovery for patients with endometrial cancer since symptoms, such as vaginal bleeding, appear early on. This leads to early detection.

While there are several screening procedures for endometrial cancer, there is no one standard test, as of now.

Three main tests may detect endometrial cancer, Dr. Matt Boente MD explains. The Pap test (or Pap smear) is where cells from the surface of the cervix and vagina are taken and viewed under a microscope. Abnormal cells may reveal cancer. Transvaginal ultrasound (TVU) looks at the vagina, uterus, fallopian tubes, and bladder and may reveal tumors through a sonogram. Finally, endometrial sampling or a biopsy, wherein tissue is removed from the endometrium, may also identify cancer cells.

Dr. Matt Boente MD specializes in obstetrics, gynecology, and gynecologic oncology. For similar reads, visit this page.

Comments

Popular posts from this blog

Outlining the key competencies of doctors

Cubs update: What a canceled season looks like

What is needed to become a fully pledged doctor?